chartexchange

SPRY
ARS Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
3.70USD+1.370%(+0.05)1,695,694
Pre-marketNov 18, 2026 8:35:30 AM EST
3.50USD-4.110%(-0.15)
After-hoursNov 18, 2026 4:00:30 PM EST
3.69USD-0.270%(-0.01)
Loading…
Loading…
371.96M
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$3.65
Beta
1.79
52-Week High
$13.15 2026-01-12
52-Week Low
$2.44 2026-11-06
SMA 50
$3.97
SMA 200
$6.94
Avg. Vol 10D
2.81M
Avg. Vol 30D
2.13M
Avg. Vol 90D
1.96M
Relative Vol
0.80
100.53M
65.96M
18,990,650
2.3100%
1,200,000
3,846
SPRY Profile

silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.

SPRY Performance
PeriodPriceDateChangeBeta
1W3.812026-11-12-2.89%5.598
1M4.232026-10-19-12.53%3.018
3M6.382026-08-19-42.01%2.765
6M7.172026-05-19-48.40%1.715
1Y7.092025-11-19-47.81%1.787
2Y13.792024-11-19-73.17%—
5Y6.002022-11-10-38.33%0.919
SPRY Stock Summary

ARS Pharmaceuticals, Inc. Common Stock (NASDAQ:SPRY) stock price today is $3.70, and today's volume is 1,695,694. SPRY is up 1.370% today. The 30 day average volume is 2.13M. SPRY market cap is $371.96M with 100.53M shares outstanding.